Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article October 21 2025
Modeling Response to High-Purity Von Willebrand Factor: Toward Tailored Dosing During Surgery in von Willebrand Disease
Research Article October 20 2025
Heme and hemozoin induce platelet cell death through UPR-induced apoptosis and ferroptosis in vivax malaria
Review Article October 20 2025
Immunotherapy in the Upfront Treatment of Adult B-cell Precursor Acute Lymphoblastic Leukemia: When, How, Who?
Research Article October 20 2025
Short- and long-term effects of transfusion in beta-thalassemia: a longitudinal study of transfusion efficiency factors
Letter October 20 2025
Danazol treatment for telomere biology disorders: long-term results of a phase I/II study
Research Article October 15 2025
Diagnostic sequencing identifies high-risk markers and mechanisms of resistance to guide immunotherapy selection.
Research Article October 15 2025
A Practical Tool for Predicting Outcomes in Essential Thrombocythemia: Triple A Risk Model and Beyond
Review Article October 15 2025
Informed Shared Decision-Making or Rigid Eligibility and Exclusion Criteria for Gene Therapy for Sickle Cell Disease?
Letter October 15 2025
AL Amyloidosis: A Real-World Experience with CAR-T Cell Therapy
Research Article October 15 2025
Azathioprine or mycophenolate mofetil for pediatric autoimmune cytopenia: A propensity score-matched study
Review Article October 10 2025
Primary and Secondary Stroke Prophylaxis in Children with Sickle Cell Anemia: A Meta-Analysis
Research Article October 10 2025
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology
Research Article October 10 2025
Targeting macrophages prevents alloantibody-mediated platelet clearance in a murine model of transfusion refractoriness
Research Article October 10 2025
Survival in Adults with High Risk TA-TMA - A Comparative Analysis of Narsoplimab Versus Supportive Care
Research Article October 8 2025
Myeloid landscape profiling identifies DLBCL-specific suppressive macrophages colocalized with blood endothelial cells
Research Article October 8 2025
Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration
Review Article October 8 2025
Predictive markers for the efficacy of CAR T-cell therapy: the interplay of CAR-T fitness and systemic immunity
Reply October 8 2025
Vaccination during bispecific antibody treatment for myeloma
Research Article October 8 2025
Combining drugs that bypass p53 to treat TP53-mutated leukemias
Research Article October 8 2025
Transplantation in lower risk MDS patients: a prospective phase 2 trial based on donor availability
Research Article October 8 2025
Effect of obexelimab on the production of anti-RBC Ab and cytokines from patients with warm autoimmune hemolytic anemia
Research Article October 8 2025
Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis and retrospective study
Research Article October 7 2025
MicroRNA-223-3p is a determinant of platelet procoagulant activity.
Research Article October 7 2025
Germline LCP1 mutations cause immunodeficiency with neutropenia, monocytopenia, lymphopenia and defective cytokinesis
Research Article October 7 2025
Use of Emergency Severity Index 2 Reduces Time to First Analgesia in Sickle Cell Disease Vaso-occlusive Crisis
Letter October 7 2025
Myeloproliferative neoplasm subtypes have distinct impact on risk of incident osteoporosis and osteoporotic fractures
Research Article October 7 2025
Risk stratification of diffuse large B-cell lymphoma patients using plasma NMR-based metabolomics at diagnostic
Research Article October 7 2025
Ablation of CD38 in Multiple Myeloma Cells Leads to an Aggressive Phenotype in a Mouse Xenograft Model
Review Article October 7 2025
Challenges and Opportunities for Improvement in the Practical Management of Adults with Acute Lymphoblastic Leukemia
Research Article October 7 2025
Phase I Study of Rogocekib in Patients with Relapsed or Refractory Hematologic Malignancies
Research Article October 6 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trial
Research Article October 6 2025
A novel isoform of Tensin1 promotes actin filament assembly for efficient erythroblast enucleation
Research Article October 6 2025
Matched Unrelated vs Haploidentical Donor Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide
Research Article October 6 2025
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
Letter October 6 2025
Time to redefine HHV-8 MCD and KICS criteria?
Review Article October 1 2025
Applying principles of vaccine development to oncomicrobial vaccines
Letter September 30 2025
Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel
Review Article September 30 2025
Antibody-DNA nanostructure conjugates integrate doxorubicin and rituximab to enhance therapeutic efficacy for DLBCL
Research Article September 30 2025
Population-scale Analysis Reveals Germline Loss of SERPING1 (C1-Inhibitor) is a Polyphenotypic Thrombotic Disorder
Research Article September 30 2025
Outcome of Patients with Mantle Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy: A Descar-T Study By Lysa Group
Research Article September 30 2025
Safety and Efficacy of Combining Midostaurin and Gemtuzumab Ozogamicin with Induction Chemotherapy in FLT3 mutated AML
Research Article September 30 2025
Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations
Letter September 30 2025
Dual Anti-CD19/22 and Anti-BCMA CAR-T cell therapy in a patient with multiple myeloma and secondary B-ALL
Research Article September 24 2025
Tumor-Specific Immune Responses and Biomarkers in pediatric High-Risk Hodgkin Lymphoma Patients
Research Article September 24 2025
Androgen receptor signaling as a new target for intervention in acute myeloid leukemia
Research Article September 24 2025
Soluble Urokinase Plasminogen Activator Receptor and Acute Kidney Injury in Hematopoietic Cell Transplantation
Research Article September 24 2025
In situ gene editing of hematopoietic stem cells via AAV-delivered CRISPR guide RNAs
Letter September 24 2025
Age-Based Pegaspargase Dosing is Safe and Achieves Therapeutic Levels in Infants with ALL: Report from COG AALL15P1
Research Article September 24 2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe
Research Article September 24 2025
Outcomes with Third Party Virus Specific T-cells After the Use of Single Antigen Cell Lines to Predict HLA Restriction
Page 2 of 4

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals